Related content

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

By Hagiwara H.   Kaizu K.   Uriu K.   Noguchi T.   Takagi I.   Qie Y.L.   Seki T.   Ariga T.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite

Enzyme immunoassay for measurement of murine plasminogen activator inhibitor-1, employing a specific antibody produced by the DNA vaccine method

By Yamada T.   Takagi A.   Takeshita K.   Yamamoto K.   Ito M.   Matsushita T.   Murate T.   Saito H.   Kojima T.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 285-291

Elsevier

Access to resources Recommend Favorite

Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications

By  

Medical Principles and Practice, Vol. 18, Iss. 4, 2009-06 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

By Lindholm Åsa   Bixo Marie   Eliasson Mats   Hudecova Miriam   Arnadottir Ragnheidur   Holte Jan   Poromaa Inger Sundström  

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite